Markets
US billionaire investor Warren Buffett
(Frederic J. Brown/Getty Images)
Buy value, get rich

Berkshire Hathaway has gotten really expensive by buying value stocks and hoarding cash

Luke Kawa
3/3/25 12:14PM

There are two ways* to get rich buying value stocks:

  1. Buying undervalued shares of companies and waiting patiently for them to converge upward to your estimate of fair value;

  2. Running a publicly traded company buying what you think are undervalued shares of companies, sitting on a ton of cash, and having investors push your stock to its highest valuation since 2008.

Over the course of its history, Warren Buffett’s Berkshire Hathaway has done a lot of No. 1, but lately it’s been enjoying No. 2.

Berkshire ended February at its highest monthly forward price-to-book ratio since 2008.

Book value is the value of a company’s assets relative to its liabilities. Granted, this metric, while elevated compared to its own history, is still at a large discount to the broad market dominated by the ascendance of relatively asset-light companies.

Around 30% of Berkshire’s assets are in cash and short-term Treasury holdings. As such, investors seem to be ascribing a fairly high value to what Warren Buffett, successor-in-waiting Greg Abel, and other deputies will be able to do with that cash, or are merely seeking solace in its size and the built-in defensiveness of that cash pile.

One thing they haven’t been doing with that cash lately: buying back their own shares. Berkshire has stamped out share repurchases even more than JPMorgan’s Jamie Dimon lately, with a grand total of $0 spent on buybacks in each of the past two quarters.

*There is a No. 3: being a hedge fund manager who buys value stocks, underperforms, but still rakes in the dough from management fees.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.